KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Opko Health (OPK) EBIAT (2016 - 2026)

Opko Health filings provide 17 years of EBIAT readings, the most recent being -$54.8 million for Q1 2026.

  • On a quarterly basis, EBIAT rose 18.88% to -$54.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$212.9 million, a 445.92% decrease, with the full-year FY2025 number at -$225.7 million, down 324.02% from a year prior.
  • EBIAT hit -$54.8 million in Q1 2026 for Opko Health, down from -$31.3 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $24.9 million in Q3 2024 to a low of -$148.4 million in Q2 2025.
  • Median EBIAT over the past 5 years was -$55.4 million (2022), compared with a mean of -$50.1 million.
  • Biggest five-year swings in EBIAT: soared 129.47% in 2024 and later crashed 1340.48% in 2025.
  • Opko Health's EBIAT stood at -$85.2 million in 2022, then grew by 22.0% to -$66.5 million in 2023, then skyrocketed by 121.1% to $14.0 million in 2024, then plummeted by 322.83% to -$31.3 million in 2025, then plummeted by 75.47% to -$54.8 million in 2026.
  • The last three reported values for EBIAT were -$54.8 million (Q1 2026), -$31.3 million (Q4 2025), and $21.6 million (Q3 2025) per Business Quant data.